Stockreport

IN8bio to Present at Upcoming Investor and Scientific Conferences in February

IN8bio, Inc.  (INAB) 
PDF NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (?d ) T cell ther [Read more]